Cibus outlines $200M annual rice royalty target while advancing global commercialization strategy

Discover key Q3 2025 insights on Cibus, Inc.—commercial momentum, rice trait expansion, cost discipline, and revenue growth.
Seeking Alpha

Cibus outlines advanced gene editing initiatives with potential revenue milestones by 2026

Interim CEO Peter Beetham emphasized the company's strategic transformation from an agricultural trait development company to a commercial gene editing company. He highlighted the progress in ...